Platelet basic protein, low-affinity platelet factor 4, and beta-thromboglobulin: purification and identification
Holt, J.C.; Niewiarowski, S.
Methods in Enzymology 169: 224-233
1989
ISSN/ISBN: 0076-6879 PMID: 2523998 Document Number: 345703
Document emailed within 1 workday
Related Documents
Arocha-Piñango, C.L.; Ojeda, A. 1983: Beta-thromboglobulin and platelet factor 4. a review Sangre 28(2): 199-209Matsuda, T.; Seki, T.; Ogawara, M.; Miura, R.; Yokouchi, M.; Murakami, M. 1980: Levels of beta-thromboglobulin and platelet factor 4 in various diseases Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 43(5): 871-878
Scharf, R.E.; Schneider, W.; Hennericic, M. 1983: Plasma levels of beta-thromboglobulin and platelet factor 4 in migraine accompagnée Deutsche Medizinische Wochenschrift 108(30): 1169-1170
Morgan, F.J.; Begg, G.S.; Chestermann, C.N.; Pepper, D.S. 1978: Partial amino acid sequence of human beta-thromboglobulin: structural relationship with platelet factor 4 Thrombosis Research 12(1): 171-175
Imaoka, S.; Nomura, T.; Ohara, S.; Tamura, Y.; Kosaki, G. 1979: Glycoprotein platelet-specific antigen and beta-thromboglobulin Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 40: 131-137
Switalska, H.I.; Niewiarowski, S.; Tuszynski, G.P.; Rucinski, B.; Schmaier, A.H.; Morinelli, T.A.; Cierniewski, C.S. 1985: Radioimmunoassay of human platelet thrombospondin: different patterns of thrombospondin and beta-thromboglobulin antigen secretion and clearance from the circulation Journal of Laboratory and Clinical Medicine 106(6): 690-700
Espevik, T.; Figari, I.S.; Ranges, G.E.; Palladino, M.A. 1988: Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1 Journal of Immunology 140(7): 2312-2316
Seguchi, M.; Nakajima, S. 1995: Induction of ICAM-1 expression on the eosinophilic leukemia cell line-3 (EoL-3) by platelet-activating factor and platelet factor 4 Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 74(3): 255-257
Hirschman, R.J.; Gralnick, H.R. 1974: A simplified platelet factor 3 (PF-3) assay for the rapid detection of platelet isoantibodies and an antiplatelet factor in ATP and SLE Journal of Laboratory and Clinical Medicine 84(2): 292-297
Satoh, M.; Endo, Y.; Mamiya, S. 1982: A basic and clinical study on platelet factor 4 (PF4) Rinsho Byori. Japanese Journal of Clinical Pathology 30(6): 673-677
Narczewska, B.; Czyrski, J.A. 1987: Partial purification of porcine platelet-derived growth factor (PDGF) Archivum Immunologiae et Therapiae Experimentalis 35(6): 831-837
Holmsen, H. 1977: Prostaglandin endoperoxide--thromboxane synthesis and dense granule secretion as positive feedback loops in the propagation of platelet responses during "the basic platelet reaction" Thrombosis and Haemostasis 38(4): 1030-1041
Hwang, S.B.; Li, C.L.; Lam, M.H.; Shen, T.Y. 1985: Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist Laboratory Investigation; a Journal of Technical Methods and Pathology 52(6): 617-630
Issekutz, A.C.; Szpejda, M. 1986: Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988 Laboratory Investigation; a Journal of Technical Methods and Pathology 54(3): 275-281
Floch, A.; Tahraoui, L.; Sedivy, P.; Cavero, I. 1991: The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes Journal of Pharmacology and Experimental Therapeutics 258(2): 567-575
Macpherson, J.L.; Kemp, A.; Rogers, M.; Mallet, A.I.; Toia, R.F.; Spur, B.; Earl, J.W.; Chesterman, C.N.; Krilis, S.A. 1989: Occurrence of platelet-activating factor (PAF) and an endogenous inhibitor of platelet aggregation in diffuse cutaneous mastocytosis Clinical and Experimental Immunology 77(3): 391-396
Ionescu, C.; Berindan-Neagoe, I.; Burz, C.; Balacescu, O.; Balacescu, L.; Tudoran, O.; Asztalos, R.; Irimie, A. 2011: The clinical implications of platelet derived growth factor B, vascular endothelial growth factor and basic fibroblast growth factor in colorectal cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 16(2): 274-276
Saito, Y.; Imada, T.; Inada, Y. 1982: Relationship between platelet adhesiveness and aggregation; isolation and analysis of membrane protein responsible for platelet adhesion in cattle Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 50: 68-75
Valone, F.H.; Epstein, L.B. 1988: Biphasic platelet-activating factor synthesis by human monocytes stimulated with IL-1-beta, tumor necrosis factor, or IFN-gamma Journal of Immunology 141(11): 3945-3950
Reed, G.L.; Matsueda, G.R.; Haber, E.; Haber, E. 1992: Platelet factor XIIi increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of alpha 2-antiplasmin to fibrin Thrombosis and Haemostasis 68(3): 315-320